TY  - GEN
AU  - Diniz,Juliana B
AU  - Costa,Daniel Lc
AU  - Cassab,Raony Cc
AU  - Pereira,Carlos Ab
AU  - Miguel,Euripedes C
AU  - Shavitt,Roseli G
TI  - The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder
SN  - 1461-7285
PY  - 2018///0116
KW  - Adult
KW  - Antidepressive Agents, Second-Generation
KW  - adverse effects
KW  - Antidepressive Agents, Tricyclic
KW  - Antipsychotic Agents
KW  - Body Dysmorphic Disorders
KW  - diagnosis
KW  - Brazil
KW  - Clomipramine
KW  - Comorbidity
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fluoxetine
KW  - Humans
KW  - Male
KW  - Obsessive-Compulsive Disorder
KW  - Prospective Studies
KW  - Quetiapine Fumarate
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1177/0269881113512042
ER  -